Alzheimer's Disease and Mild Cognitive Impairment

Brendan J. Kelley; Ronald C. Petersen

doi:10.1016/j.ncl.2007.03.008

Alzheimer's Disease and Mild Cognitive Impairment

Brendan J. Kelley, Ronald C. Petersen

Research output: Contribution to journal › Review article › peer-review

244 Scopus citations

Abstract

As our society ages, age-related diseases assume increasing prominence as both personal and public health concerns. Disorders of cognition are particularly important in both regards, and Alzheimer's disease is by far the most common cause of dementia of aging. In 2000, the prevalence of Alzheimer's disease in the United States was estimated to be 4.5 million individuals, and this number has been projected to increase to 14 million by 2050. Although not an inevitable consequence of aging, these numbers speak to the dramatic scope of its impact. This article focuses on Alzheimer's disease and the milder degrees of cognitive impairment that may precede the clinical diagnosis of probable Alzheimer's disease, such as mild cognitive impairment.

Original language	English (US)
Pages (from-to)	577-609
Number of pages	33
Journal	Neurologic Clinics
Volume	25
Issue number	3
DOIs	https://doi.org/10.1016/j.ncl.2007.03.008
State	Published - Aug 2007

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1016/j.ncl.2007.03.008

Cite this

@article{1087eb0641f84fc299eb3add269de638,

title = "Alzheimer's Disease and Mild Cognitive Impairment",

abstract = "As our society ages, age-related diseases assume increasing prominence as both personal and public health concerns. Disorders of cognition are particularly important in both regards, and Alzheimer's disease is by far the most common cause of dementia of aging. In 2000, the prevalence of Alzheimer's disease in the United States was estimated to be 4.5 million individuals, and this number has been projected to increase to 14 million by 2050. Although not an inevitable consequence of aging, these numbers speak to the dramatic scope of its impact. This article focuses on Alzheimer's disease and the milder degrees of cognitive impairment that may precede the clinical diagnosis of probable Alzheimer's disease, such as mild cognitive impairment.",

author = "Kelley, {Brendan J.} and Petersen, {Ronald C.}",

note = "Funding Information: The authors would like to acknowledge the support for preparation of this article and research reported herein from the National Institute on Aging P50 AG16574, U01 AG06786, and the Robert H. and Clarice Smith and Abigail van Buren Alzheimer's Disease Research Program. ",

year = "2007",

month = aug,

doi = "10.1016/j.ncl.2007.03.008",

language = "English (US)",

volume = "25",

pages = "577--609",

journal = "Neurologic Clinics",

issn = "0733-8619",

publisher = "W.B. Saunders Ltd",

number = "3",

}

TY - JOUR

T1 - Alzheimer's Disease and Mild Cognitive Impairment

AU - Kelley, Brendan J.

AU - Petersen, Ronald C.

N1 - Funding Information: The authors would like to acknowledge the support for preparation of this article and research reported herein from the National Institute on Aging P50 AG16574, U01 AG06786, and the Robert H. and Clarice Smith and Abigail van Buren Alzheimer's Disease Research Program.

PY - 2007/8

Y1 - 2007/8

N2 - As our society ages, age-related diseases assume increasing prominence as both personal and public health concerns. Disorders of cognition are particularly important in both regards, and Alzheimer's disease is by far the most common cause of dementia of aging. In 2000, the prevalence of Alzheimer's disease in the United States was estimated to be 4.5 million individuals, and this number has been projected to increase to 14 million by 2050. Although not an inevitable consequence of aging, these numbers speak to the dramatic scope of its impact. This article focuses on Alzheimer's disease and the milder degrees of cognitive impairment that may precede the clinical diagnosis of probable Alzheimer's disease, such as mild cognitive impairment.

AB - As our society ages, age-related diseases assume increasing prominence as both personal and public health concerns. Disorders of cognition are particularly important in both regards, and Alzheimer's disease is by far the most common cause of dementia of aging. In 2000, the prevalence of Alzheimer's disease in the United States was estimated to be 4.5 million individuals, and this number has been projected to increase to 14 million by 2050. Although not an inevitable consequence of aging, these numbers speak to the dramatic scope of its impact. This article focuses on Alzheimer's disease and the milder degrees of cognitive impairment that may precede the clinical diagnosis of probable Alzheimer's disease, such as mild cognitive impairment.

UR - http://www.scopus.com/inward/record.url?scp=34447303785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447303785&partnerID=8YFLogxK

U2 - 10.1016/j.ncl.2007.03.008

DO - 10.1016/j.ncl.2007.03.008

M3 - Review article

C2 - 17659182

AN - SCOPUS:34447303785

SN - 0733-8619

VL - 25

SP - 577

EP - 609

JO - Neurologic Clinics

JF - Neurologic Clinics

IS - 3

ER -

Alzheimer's Disease and Mild Cognitive Impairment

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this